Skip to Main Content

Paper Details

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
J Clin Oncol
14
2022
) Cancer, -, E6, HPV16, HPV16-E6 oncoprotein, Human, Human Papillomavirus Cancer, OPC, Oropharyngeal Cancer, human papillomavirus, oropharyngeal cancer, participants, people
Author NameAffiliation
Lesley F TinkerFred Hutchinson Cancer Research Center
Kristian HveemHUNT Research Center and K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology
Dimitrios TrichopoulosFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Rudolf KaaksGerman Cancer Research Center (DKFZ)
María-José Sánchez
María-José SánchezUniversity of Granada
María-José SánchezCentro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP)
María-José SánchezInstituto de Investigacion Biosanitaria (ibs.GRANADA)
Graham G Giles
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Graham G GilesThe University of Melbourne
Roger L Milne
Roger L MilneSchool of Clinical Sciences at Monash Health, Monash University
Roger L MilneThe University of Melbourne
Qiuyin CaiVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
William J BlotVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Wei ZhengVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Stephanie J WeinsteinNational Cancer Institute
Demetrius AlbanesNational Cancer Institute
  • 1 - 19

Datasets

Release 1.2